Blog | HemaCare

p11 Levels Increase in Peripheral Blood Mononuclear Cells from Patients with Parkinson’s Disease

Nov 9, 2016 12:00:00 AM / by Stacy Matthews Branch, DVM, PhD posted in p11, PBMCs, stem cell research, Stem Cell Therapy, CNS/Neurodegeneration, Basic Research


Depression is a common and challenging component of Parkinson’s disease (PD). Up to 70% of patients with PD experience depression. This clinical symptom is not only a result of PD, but a part of the condition itself. Study findings have shown that inflammation not only plays a part in the physical signs of PD, but is also involved in the development of depression. The increase in inflammatory mediators, such as cytokines, in PD is detectable before signs of PD begin. These mediators may serve as important biomarkers of PD that can be utilized to detect PD and allow early intervention.

Read More

      Subscribe Here!

      Posts by Topic

      see all

      Recent Posts